Tesamorelin, a synthetic peptide analog of somatotropin-releasing hormone, is mainly applied in the treatment of visceral adipose tissue in individuals affected by HIV. This compound works by stimulating the release of human growth hormone from the pituitary structure, which in turn can help in reducing abdominal fat accumulation . While not cure f

Emerging retatrutide, a combined-action drug targeting both GLP-1 and GIP receptors, is creating considerable interest within the healthcare community. Early clinical studies have shown significant losses in physical weight and advancements in physiological markers for patients with obesity . Scientists believe this unique approach could mark a key